Business and People News — 8-22
People News
uMotif has appointed three new executive leaders: Gary Parrott as Chief Financial Officer, Kristine Klinger as Chief Delivery Officer, and Elaine Maynard as Vice President Marketing.
Worldwide Clinical Trials added Tom Zhang, PhD to the company's early phase clinical trials leadership team as Chief Scientist, Large Molecule Bioanalysis.
Suvoda LLC announced the hiring of Jill Platko, PhD as Vice President of Scientific Services.
Dr. Vince Clinical Research announced the addition of Michelle Neaderhiser as the Director of Study Management, and Chris Hardage as the Director of Clinical Trial Services.
THREAD announced the executive appointment of Kim Boericke as Chief Delivery Officer.
Xenia Kovacs has joined HeartcoR Solutions as associate director of project management.
WCG announced it has appointed its first Chief Product Officer, Rahul Bafna.
Business News
AARDEX Group and BIOCORP announced they have been recruited by Trials@Home to take part in a Phase IV study called RADIAL.
Clinical trial sponsors have relied on Calyx’s Interactive Response Technology (IRT) System in clinical trials supporting the approval of over 150 orphan drug indications, as designated by global regulators.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
